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Abstract The reaction of human serum apotransferrin with
titanium(IV) citrate under physiological conditions results in the
formation of a specific bis-titanium(IV) transferrin adduct
(Ti2Tf hereafter) with two titanium(IV) ions loaded at the iron
binding sites. The same specific Ti2Tf complex is formed by
reacting apotransferrin with titanium(III) chloride and exposing
the sample to air. The derivative thus obtained was characterized
by spectroscopic techniques, including absorption, UV difference,
circular dichroism and 13C NMR spectroscopies, and shown to
be stable within the pH range 5.5^9.0. Surprisingly, the reaction
of apoTf with titanium(IV) nitrilotriacetate (NTA) does not lead
to formation of appreciable amounts of Ti2Tf, even after long
incubation times, although some weak interactions of Ti(IV)-
NTA with apoTf are spectroscopically detected. Implications of
the present results for a role of transferrin in the uptake,
transport and delivery of soluble titanium(IV) compounds under
physiological conditions are discussed.
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1. Introduction
Transferrin is the principal iron transport protein in higher
organisms [1^3]. Owing to the high stability of the iron com-
plex, transferrin prevents hydrolysis of iron(III) at physiolog-
ical pH and allows delivery of the essential iron(III) ions to
the various compartments of the body through a sophisticated
receptor-mediated mechanism [3]. Under normal conditions,
transferrin is only 30% iron-saturated, and therefore may act
as a speci¢c carrier for several other tripositive, tetrapositive
and bipositive metal ions. The ability of transferrin to bind to
a variety of metal ions besides iron, preventing their precip-
itation at physiological pH, is well-documented [4]. Thus,
transferrin may have a signi¢cant impact on the metabolism
and the biodistribution of trace elements but may also poten-
tiate the deleterious e¡ects of toxic metal ions such as acti-
nides, that otherwise would not be bioavailable [5]. Extensive
studies now exist on this topic [6].
The demonstrated ability of transferrin to interact with sev-
eral metal ions prompted us to study the interaction of human
serum apotransferrin with titanium(IV) complexes. Titanium
is, indeed, a relatively abundant element with a number of
industrial and biomedical applications. Titanium compounds
are generally poorly soluble and poorly bioavailable; thus
toxicology of titanium essentially deals with the local e¡ects
of orthopedic titanium implants [7] and with lung damage
caused by titanium dioxide particles [8]. Very limited data
exist on the biological e¡ects and the toxicity of soluble tita-
nium(IV) complexes. In our opinion, however, this topic de-
serves particular attention, given the growing use of titanium
implants in medicine and the possible release of soluble tita-
nium species in vivo. In the latter case it is likely that trans-
ferrin may act as a speci¢c carrier of this metal ion and may
play a central role in the transport and biodistribution of
soluble titanium species throughout the organism [9].
Thus, we selected two representative, water-soluble
titanium(IV) complexes ^ namely titanium(IV) citrate and ti-
tanium(IV) nitrilotriacetate [Ti(IV)NTA], both stable within a
physiological environment ^ and monitored their reactions
with human serum apotransferrin (apoTf hereafter) at pH
7.4. The formation of adducts with apoTf and their stability
as a function of pH were investigated by a variety of spectro-
scopic methods. Elucidation of the reactions between
titanium(IV) complexes and apotransferrin, the key protein
for the transport of highly charged metal ions in the blood
stream, will contribute to understanding the metabolism in
vivo of this widespread element and shed light on the molec-
ular mechanisms of its biological (or toxic) e¡ects. By analogy
with the case of aluminum(III) and gallium(III) complexes
[10,11], it is likely that soluble titanium complexes may follow
in vivo the biological route of iron(III) and may in this way
exert their e¡ects.
2. Materials and methods
2.1. Materials
Titanium(IV) citrate was prepared by mixing titanium(III) chloride
with a 1.2-fold excess of sodium citrate at pH 3; exposure to air
caused quantitative oxidation of titanium(III) citrate to colorless tita-
nium(IV) citrate. A similar method was used to prepare titanium-
(IV)NTA. Human serum apoTf was purchased from Sigma Chemical
Company and used as such; its concentration was determined by
measuring its UV absorbance at 280 nm (O280 = 91 200 M31 cm31).
The other reagents were of analytical grade.
2.2. Circular dichroism (CD), UV di¡erence and absorption spectra
CD spectra were carried out at room temperature with a Jasco J500
instrument interfaced with a PC. Samples for CD measurements con-
tained 1U1034 M human serum apotransferrin, prepared in 50 mM
HEPES bu¡er, 100 mM sodium bicarbonate, pH 7.4. Data analysis
was performed with the standard JASCO software package. UV-visi-
ble absorption spectra were recorded with a Perkin Elmer Lambda 20
instrument. UV di¡erence spectra were measured according to the
previously reported method [12]; samples usually contained
V1U1035 M apotransferrin. The kinetics of metal uptake and release
processes were followed through spectrophotometry and CD.
2.3. NMR spectra
The 13C NMR spectra were acquired on a Bruker Avance 600
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instrument working at 150 MHz. Samples for 13C NMR measure-
ments contained 1.5 mM transferrin, 50 mM HEPES bu¡er, pH
7.4, and 10% D2O, in a volume of about 0.5 ml. 13C-enriched sodium
bicarbonate (6 mM ¢nal concentration) was added to the samples
before addition of a twofold excess of titanium(IV) citrate. Typically
13C NMR acquisition parameters used in this study were as follows:
70‡ pulse length, 3.0 s repetition time, 20 000 Hz sweep width. A line
broadening of 10^30 Hz was applied to 13C data prior to processing.
3. Results
3.1. Preparation of titanium(IV) transferrin starting from
titanium(IV) citrate
The reaction of apoTf with titanium(IV) citrate was ¢rst
followed through CD spectroscopy, which represents a very
appropriate tool to detect metal binding to chiral macromo-
lecules [13]. Addition of titanium(IV) citrate to apotransferrin
at physiological pH (2:1 Ti/apoTf molar ratio) results in the
appearance of an intense CD band at 310 nm, with a pro-
nounced shoulder at 330 nm, suggesting the formation of a
speci¢c Ti2Tf derivative (Fig. 1A). These bands, tentatively
assigned as ligand to metal charge transfer (LMCT) bands,
slowly develop with time, reaching maximum intensity within
about 6 h at 20‡C; afterwards the spectrum is stable for days.
The same reaction was monitored through UV di¡erence
spectroscopy. This revealed characteristic UV di¡erence bands
at 240 and 290 nm, diagnostic of phenolate deprotonation and
titanium binding to the iron sites [12]. Again, a LMCT band
is detected at 320 nm (Fig. 1B).
Titration studies (both CD and absorption) show that
transferrin speci¢cally binds ca. 2 mole titanium(IV) per mol
protein, in good agreement with the hypothesis that titanium-
(IV) ions occupy the empty metal binding sites of transferrin
(data not shown). Only weak binding is observed when tita-
nium(IV) citrate is added in excess of a 2:1 stoichiometry. The
pro¢les of CD and absorption titrations of apoTf with in-
creasing amounts of titanium(IV) citrate at pH 7.4 are rather
regular, suggesting that the two sites are nearly identical. No-
tably, the presence of the synergistic carbonate anion is re-
quired for binding.
3.2. Preparation of titanium transferrin starting from
titanium(III) chloride
Remarkably, the same Ti2Tf derivative could be prepared
by reacting apoTf with titanium(III) chloride anaerobically
(2:1 Ti/apoTf ratio) and oxidizing the sample in the air.
Such an experiment leads ¢rst to formation of titanium(III)
transferrin, which then oxidizes to titanium(IV) transferrin
when exposed to air. Conversion from Ti(III) to Ti(IV) trans-
ferrin is directly monitored by measuring the spectral changes
in the 300^400 nm region (Fig. 2). Notably, the ¢nal species is
spectroscopically identical to that obtained starting from tita-
nium(IV) citrate.
3.3. pH-dependent properties of Ti(IV) transferrin
We next investigated the stability of the obtained titanium-
(IV) transferrin derivative (Ti2Tf) as a function of pH. Both
CD and spectrophotometric results indicate that Ti2Tf is quite
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Fig. 1. A: CD spectra of apoTf at increasing times after addition of
titanium(IV) citrate (2:1 Ti/apoTf molar ratio). Spectra were taken
before addition (a) and 1 (b), 5 (c), 15 (d), 30 (e), 90 (f), 210 (g)
and 420 (h) min after titanium(IV) citrate addition. Conditions were
the following: apoTf 1U1034 M; 50 mM HEPES bu¡er, 100 mM
sodium bicarbonate, pH 7.4. B: UV di¡erence spectra of apoTf at
increasing times after addition of titanium(IV) citrate (2:1 Ti/apoTf
molar ratio). Spectra were collected at the following times after mix-
ing: 10, 20, 30, 40, 60, 80, 120, 160, 210, 330, 390 and 420 min.
ApoTf concentration was 1U1035 M; the other conditions as in A.
Fig. 2. Spectrophotometric monitoring of titanium(III) to titanium-
(IV) transferrin interconversion, measured in the 300^400 nm region.
Spectrum a, apoTf; b and c, apoTf, 5 and 10 min after addition of
Ti(III) citrate (2:1 Ti/apoTf molar ratio); spectra d, e, f, g, h were
taken at increasing times after opening the cuvette and exposing the
sample to air (80^260 min). Other conditions as in Fig. 1A.
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stable within the pH range 5.5^9.0. So Ti2Tf is more stable
than other metallotransferrins at low pH, breaking down only
for pH values lower than 5.0. In contrast, Ti2Tf is relatively
less stable at high pH; indeed, at pH 9.7 more than 60% of
the original spectral intensity is lost without evidence of con-
formational changes (Fig. 3), whereas other metallotransfer-
rins (e.g. cobalt(III), iron(III), aluminum(III) transferrin, etc.)
were previously reported to be stable up to pHW11 [14]. The
behavior of titanium(IV) transferrin at high pH reproduces
that of thallium(III) transferrin [15] suggesting that in both
cases for pH values v9.0 hydroxide precipitation is favored
over formation of the respective transferrin derivative.
3.4. Reaction of apoTf with Ti(IV)NTA
Surprisingly, reaction of apoTf with Ti(IV)NTA gives rise
to substantially di¡erent CD and UV di¡erence spectra as
compared to titanium(IV) citrate (Fig. 4). The absence of
the characteristic tyrosine deprotonation bands at 240 and
290 nm suggests that speci¢c binding of titanium(IV) at the
iron sites does not take place in this case. Only residual e¡ects
at 240 and 290 nm are observed in the UV di¡erence spectra,
possibly indicating formation of a very limited amount of
Ti2Tf (ca. 10^15% as compared to the case of titanium(IV)
citrate). Failure to form Ti2Tf starting from Ti(IV)NTA is
ascribed to the fact that Ti(IV)NTA is far more stable than
titanium(IV) citrate, so that transfer of titanium(IV) ions from
NTA to apoTf is disfavored. This hypothesis was con¢rmed
through a simple CD experiment demonstrating that a slight
excess of the NTA anion is able to scavenge more than 70% of
the bound titanium from titanium transferrin within a few
hours. Conversely, observation of CD e¡ects following addi-
tion of Ti(IV)NTA to apoTf indicates that some speci¢c in-
teractions indeed occur between this metal complex and the
apoprotein.
3.5. 13C NMR studies
As previously reported for several other metallotransferrins
[16,17], observation of the characteristic 13C NMR signal of
protein-bound, 13C-enriched synergistic anion provides evi-
dence that the ternary protein-metal-anion adduct has
formed. 13C NMR spectra were recorded at 150 MHz on
Ti2Tf samples prepared with 13C-enriched sodium bicarbon-
ate. Indeed, a new 13C NMR signal corresponding to protein-
bound carbonate could be observed at 166.7 ppm (signal a in
Fig. 5); the position of the signal agrees quite well with that
observed for other metallotransferrins [16,17], although the
present 13C NMR signal of Ti2Tf-bound carbonate is signi¢-
cantly broader and weaker than in previously reported cases.
4. Discussion
4.1. Formation of Ti2Tf by reaction with titanium(IV) citrate
Transferrin is known to act as a general ligand for many
metal ions of di¡erent charge and size besides the physiolog-
ical iron(III) ions. Since in vivo transferrin is largely present
as the apo-form, this protein is often involved in the biodis-
tribution and metabolism of metal ions that are known to be
either trace elements or pollutants. In the present study, we
considered the reactions of apotransferrin with two represen-
tative titanium(IV) complexes, i.e. titanium citrate and tita-
nium nitrilotriacetate, under physiological conditions, to es-
tablish whether such reactions lead to quantitative formation
of the corresponding titanium(IV) transferrin adducts.
A rather stable Ti2Tf derivative does indeed form when
apotransferrin is reacted with titanium(IV) citrate at physio-
logical pH; UV di¡erence spectra provide evidence that bind-
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Fig. 3. pH dependence of the electronic spectra of bis-titanium(IV)
transferrin in the high pH region. Spectra were taken at the follow-
ing pH values: 7.40 (a); 7.93 (b); 8.50 (c); 9.70 (d); 10.50 (e); 11.50
(f). Other conditions as in Fig. 1A.
Fig. 4. E¡ects of the addition of titanium(IV) nitrilotriacetate (2:1
Ti/apoTf molar ratio) on the CD (A) and the UV di¡erence spectra
(B) of apoTf. CD spectra were taken before (a) and 1 min (b),
8 min (c), 30 min (d) and 480 min (e) after addition of Ti(IV)NTA.
UV di¡erence spectra were taken 1 min (a), 5 min (b), 10 min (c),
80 min (d), 140 min (e), 200 min (f) and 260 min (g) after Ti(IV)-
NTA addition. Conditions for the CD spectra were as in Fig. 1A;
those for UV di¡erence spectra were as in Fig. 1B.
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ing of titanium occurs at both transferrin sites and causes
tyrosine deprotonation. The reaction characteristically exhib-
its a stoichiometry of two titanium ions per protein molecule
and reaches completion within a few hours after mixing. The
characteristic signal of protein-bound carbonate revealed in
the 13C NMR spectra further supports our conclusions. The
same Ti2Tf derivative may be prepared by addition of
titanium(III) chloride to apoTf followed by oxidation of the
sample in air; oxidation of titanium(III) transferrin to
titanium(IV) transferrin can be directly monitored through
spectrophotometric analysis of the 400^300 nm region.
Surprisingly, reaction of apotransferrin with Ti(IV)NTA
does not result in formation of the corresponding titanium-
(IV) transferrin adduct as in the case of titanium(IV) citrate;
only a very limited amount of titanium transferrin apparently
forms. This fact is ascribed to the higher stability of titanium-
(IV) nitrilotriacetate compared to titanium(IV) citrate. In any
case limited interactions of Ti(IV)NTA with the protein are
detected, which likely correspond to formation of hydrogen
bonds and/or electrostatic interactions of Ti(IV)NTA with
amino acid residues situated in proximity of the empty sites
of transferrin.
4.2. pH-dependent properties
Ti2Tf exhibits an unusual pH dependence pro¢le; in fact,
while this derivative is stable in the pH range 5.5^9.0, it rap-
idly breaks down above pH 9. Thus, while being considerably
stable at low pH, it is relatively unstable at high pH. The
lower stability of Ti2Tf at high pH compared to other metal-
lotransferrins probably re£ects the fact that transferrin is no
longer able to prevent titanium(IV) (hydr)oxide formation, as
previously observed in the case of thallium(III) transferrin.
4.3. Implications for the in vivo metabolism of soluble
titanium species
Overall, the present study unambiguously demonstrates
that a stable adduct between titanium(IV) and apotransferrin
forms under physiological conditions, provided that
titanium(IV) is presented to the protein as the appropriate
titanium(IV) complex. Titanium(IV) citrate was shown to
meet these requirements whereas Ti(IV)NTA was not able
to transfer Ti(IV) ions to the metal binding sites of apotrans-
ferrin. Though preliminary, our results may be of interest for
studies of the in vivo metabolism of soluble titanium(IV) com-
plexes; for example, it might be hypothesized that, when in-
jected into the blood stream, titanium(IV) citrate will form
substantial amounts of titanium(IV) transferrin and will fol-
low the typical route of iron ions.
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